Xeris Biopharma Holdings, Inc. XERS Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeOther.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s interest income?
- Xeris Biopharma Holdings, Inc. (XERS) reported interest income of $1.2M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s interest income changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s interest income increased by 2.3% year-over-year, from $1.18M to $1.2M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s interest income?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s interest income has grown at a 97.3% compound annual growth rate (CAGR), from $313K to $4.74M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.